ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$128 | -$101 | -$89 | -$79 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $20 | $15 | $14 | $13 |
| Change in WC | $2 | $5 | -$0 | $4 |
| Other Non-Cash | -$8 | -$6 | -$1 | $1 |
| Operating Cash Flow | -$113 | -$86 | -$75 | -$60 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $2 | $1 |
| Inv. Purchases | -$252 | -$239 | -$238 | -$70 |
| Inv. Sales/Matur. | $275 | $197 | $131 | $229 |
| Other Inv. Act. | $0 | $0 | -$2 | -$1 |
| Investing Cash Flow | $22 | -$43 | -$109 | $158 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $125 | $85 | $25 | $50 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $1 | $0 | -$1 |
| Financing Cash Flow | $127 | $86 | $25 | $49 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $36 | -$43 | -$159 | $148 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24 | $67 | $226 | $78 |
| End Cash | $60 | $24 | $67 | $226 |
| Free Cash Flow | -$114 | -$87 | -$77 | -$60 |